The paper analyzes the potential of machine learning in disease prediction and its integration into healthcare systems, offering a proactive healthcare strategy. ML-driven disease prediction combines ...
A new study by the National Cancer Research Center (CNIO) has identified several sets of genes related to the predisposition ...
A new study by the National Cancer Research Centre (CNIO) has identified several sets of genes related to the predisposition ...
The US Food and Drug Administration (FDA) has granted Fast Track Designation to Complement Therapeutics’ CTx001, the ...
Proteinuria (protein in urine) is common with complement 3 glomeropathy and is a strong predictor of disease progression and end-stage kidney failure.
Verywell Health on MSN
How complement 3 glomerulopathy is diagnosed: Step-by-step
Medically reviewed by Jamin Brahmbhatt, MD Key Takeaways Complement 3 glomerulopathy (C3G) is diagnosed with a combination of ...
This knowledge would help identify individuals who could benefit from early detection programmes, which are essential for a ...
Neuroimmune diseases, such as multiple sclerosis, myasthenia gravis, and autoimmune encephalitis, are debilitating conditions ...
Potential to Be the First Targeted Fast-Acting Therapy for GBS, Setting a New Standard of Care BLA Submission with U.S./European Data from ...
The SleepFM model reveals how sleep analysis can predict disease risk, offering insights into sleep's role as a vital health ...
From football fields to military training grounds, head injuries are leaving lasting marks on the brain in ways we're only ...
As we head into the 2026, let's take a look at biotech licensing deals and M&As that were inked in December 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback